To include your compound in the COVID-19 Resource Center, submit it here.

Salirasib: Phase II data

Data from 27 evaluable patients in an ongoing, open-label Phase II trial showed that 10

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE